Danış, N. et al. 2019. Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. Turkish Journal of Gastroenterology. 30, 8 (Jan. 2019), 695–701. DOI:https://doi.org/10.5152/tjg.2019.18833.